Correlation between egfr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma

Table 1 Treatment characteristics of the selected group

Author	Fractionation	OTT(days)	SI_H %	SI_L %	LCR_H	LCR_L	HR	S
Eriksen AO a [6]	33x2Gy	66	SI ≥ 50	SI < 50	0.15	0.44	Y	N
Eriksen AO b [6]	33x2Gy	45	SI ≥ 50	SI < 50	0.64	0.55	Y	N
Eriksen AO c [6]	33x2Gy	38	SI ≥ 50	SI < 50	0.77	0.57	Y	N
Eriksen RO a [7]	33x2Gy	45	SI ≥ 50	SI < 50	0.57	0.63	Y	N
Eriksen RO b [7]	33x2Gy	38	SI ≥ 50	SI < 50	0.70	0.62	Y	N
Bentzen JCO a [8]	33x2Gy	45	SI ≥ 40	SI < 40	0.30	0.45	N	N
Bentzen JCO b [8]	36x1.5 Gy	12	SI ≥ 40	SI < 40	0.54	0.49	N	N
Suwinski IJROBP a [9]	35x1.8 Gy	47	SI ≥ 33	SI < 33	0.33	0.70	N	Y
Suwinski IJROBP b [9]	35x1.8 Gy	35	SI ≥ 33	SI < 33	0.58	0.73	N	Y
Smid IJROBP a [10]	25x2Gy + 5x2.5 Gy	~ 46	A/m	M/I	0.69	0.65	N	Y
Smid IJROBP b [10]	25x2Gy + 5x2.5 Gy	~ 34	A/m	M/I	0.91	0.68	N	Y
Chung IJROBP a [11]	35x2Gy	47	SI ≥ 80	SI < 80	0.36	0.61	N	N
Chung IJROBP b [11]	30x1.8 Gy + 12x1.5 Gy	38	SI ≥ 80	SI < 80	0.54	0.68	N	N

Abbreviations: SI = Staining Intensity cut-point; A/m = Absent/minimal; M/I = Moderate/Intense; HR = Hypoxic Radiosensitizer; S = Surgery.

ISSN: 1748-717X